GNBT Stock Performance, Insider Transaction and News

GNBT - GENEREX BIOTECHNOLOGY CORP

Market Cap	71.07K	P/E	-	EPS this Y	-	Ern Qtrly Grth	-
Income	-37.26M	Forward P/E	-	EPS next Y	-	50D Avg Chg	-48.00%
Sales	692.76k	PEG	-	EPS past 5Y	-	200D Avg Chg	-91.00%
Dividend	N/A	Price/Book	0.00	EPS next 5Y	17.50%	52W High Chg	-100.00%
Recommedations	-	Quick Ratio	0.03	Shares Outstanding	118.45M	52W Low Chg	500.00%
Insider Own	-	ROA	-43.84%	Shares Float	116.43M	Beta	-0.06
Inst Own	0.02%	ROE	-	Shares Shorted/Prior	211.98K/101.16K	Price	0.00060
Gross Margin	48.24%	Profit Margin	-	Avg. Volume	15,802	Target Price	-
Oper. Margin	-4,952.49%	Earnings Date	Jun 17	Volume	1,058	Change	0.00%

Healthcare | Biotechnology | United States

About GENEREX BIOTECHNOLOGY CORP

Generex Biotechnology Corporation, through its subsidiaries, engages in the administration of formulations of large molecule drugs to the oral cavity using a hand-held aerosol applicator in Canada and the United States. It offers Generex Oral-lyn, an oral insulin product. The company is also developing AE37, a synthetic peptide vaccine, which has completed Phase IIb clinical trial to stimulate a potent and specific immune response against tumors expressing the HER-2/neu oncogene in patients with breast cancer and prostate cancer. In addition, it develops, manufactures, and distributes rapid point-of-care in-vitro medical diagnostics for infectious diseases, such as human immunodeficiency virus, tuberculosis, malaria, hepatitis B, hepatitis C, syphilis, and others; and test kits and cassettes for testing infectious diseases, as well as Excellagen, a wound conforming gel. Further, the company is developing immunotherapeutic products and vaccines; and extracellular matrix hydrogel solution, a tissue engineered therapy for the treatment of Ulcerative Colitis. Additionally, it manufactures and sells foot and ankle surgical kits that include plates, screws, and tools; and distributes surgical supplies, orthopedic implants, artificial joints, and biologics, medical devices, and regenerative medicine products. It also serves as the general partner of the Management Services Organization. Generex Biotechnology Corporation was founded in 1983 and is headquartered in Miramar, Florida. On April 23, 2022, an involuntary petition for liquidation under Chapter 7 was filed against Generex Biotechnology Corporation in the U.S. Bankruptcy Court for the Southern District of Florida. On June 6, 2022, the involuntary petition was approved by the Court.

GNBT Chatroom

cctranscripts Posted - 06/25/15

Preliminary Proxy Soliciting materials http://stks.co/g2eDg $GNBT

cctranscripts Posted - 06/25/15

Generex Biotechnology: Generex Announces Capital Investment http://stks.co/i2eZ5 $GNBT

greenlunch12 Posted - 06/08/15

$GNBT

cctranscripts Posted - 8 years ago

Generex Biotechnology Corporation just filed its Quarterly report [Sections 13 or 15(d)] http://stks.co/f2Vkk $GNBT

cctranscripts Posted - 8 years ago

Other preliminary proxy statements http://stks.co/h2U4D $GNBT

greenlunch12 Posted - 05/21/15

$GNBT

greenlunch12 Posted - 05/18/15

$GNBT how come this holding cant make on stocktwits ? its gonna be huge somedayyyyy !

greenlunch12 Posted - 05/18/15

$GNBT

Daniel_Ward Posted - 05/09/15

Updated #ASCO15 Small Cap Primer Before Wed Release. Newly added: $TCON $INFIQ $IPHYF ( $IPH ) $IMMU $CRIS $GNBT

Daniel_Ward Posted - 05/06/15

#ASCO15 small caps gainers today, abstracts in 1 week: $ARRY +8.1%, $DRNA +6.4% (preclin data #TIDES2015), $GNBT +5.8% (penny), $AGEN +4.1%

Ish_Capital Posted - 9 years ago

"@Keynesonomics: Biotech: $DVAX $CDMO $BPTH $ATNM $OCUP $MATN $SVRA $SRPT $TOVX $WGBS $ARMP $ELTP $GNBT New: $TLOG On Watch: $PGEN $KPTI. $IBB

cctranscripts Posted - 04/27/15

Generex Biotechnology Corporation director just picked up 5,874,162 shares http://stks.co/h2Cfa $GNBT

HazzMatt Posted - 04/24/15

$GNBT So ST says this is up 9%, with a "0" price increase. How does that work?

ckruel Posted - 04/24/15

$GNBT stock starting to show signs of waking up from long hibernation

ckruel Posted - 04/23/15

@Keynesonomics $gnbt if partnership onthe diabetes side.say Sherya outof India who financed part of stdy or an ae37 prtner this will rocket

ckruel Posted - 04/23/15

@Keynesonomics $gnbt if thisco gets it's act together there are so many opps for it's product from inhaler usage,diabetes, cancer etc

ckruel Posted - 04/22/15

$GNBT artc. http://stks.co/g2ASa

Ish_Capital Posted - 04/22/15

"@Keynesonomics: Biotech: $DVAX $CDMO $SRPT $TOVX $OCUP $MEIP $SVRA $MATN $ATNM $ELTP $GNBT $PHIO New: $KBIO $IMUC $BPTH

ckruel Posted - 04/21/15

@Keynesonomics $gnbt http://stks.co/e2573

Ish_Capital Posted - 04/16/15

"@ckruel: $SVRA $ARTX $MATN $APPY $ATNM $CDMO $GNBT $TOVX $TRVN $MDM $NGD $BIOD $KOPN $THLD

pgerakis Posted - 04/13/15

long- $CRK $EGC $GDP $NSPR $GNBT $SGYP $FCEL

TGMF Posted - 04/10/15

$ALR $BIOD $ASRT $DXCM $GNBT $MNKD $PODD $PMCB http://stks.co/p1po7

ckruel Posted - 04/10/15

$mstx $artx $oxgn $appy $atnm $pphm $gnbt $syn $trvn $mdm $ngd $biod $kopn $thld for btr or worse...looooong

BVHealthcare Posted - 04/07/15

$GNBT Generex Biotechnology Corp files Form 8-K (Events or Changes Between Quarterly Reports) SEC Fili.. http://stks.co/t1oll

pgerakis Posted - 9 years ago

$CRK $SGYP $FCEL $GNBT $NSPR LONG - $GDP $EGC SHORT.

pgerakis Posted - 9 years ago

$CRK $NSPR $FCEL $GNBT LONG .- $GDP $EGC SHORT.

nikunjsatani Posted - 03/12/15

$GNBT http://stks.co/q1gSb

TheHookingBull Posted - 03/12/15

$GNBT Float 800. Going no where

cctranscripts Posted - 03/06/15

Generex Biotechnology Corporation just filed its Quarterly report [Sections 13 or 15(d)] http://stks.co/a1qkU $GNBT

BVHealthcare Posted - 03/06/15

$GNBT Generex Biotechnology Corp files Form 10-Q (Quarterly Reports) SEC Filing.. http://stks.co/j1vPL